ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE

$9.43

$+1.07

(+12.86%)

Ginkgo Bioworks Holdings, Inc. (DNA) Live Price Chart

Page last updated: 2026-02-06 11:01:00

Key Market Data

Market Cap	$457.33M
Open	$8.83
High	$39,999.60
Low	$0.40
Previous Close	$8.32
Price Change	$+1.07
Percentage Change	+12.86%
Volume	13K

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price Today

Ginkgo Bioworks Holdings, Inc. (DNA) is currently trading at $9.43 as of 2026-02-06 11:01:00, reflecting a +12.86% move ($+1.07) from the previous close.

In the short term, the stock has returned +402.87% over the past four weeks. Over the last 12 months, Ginkgo Bioworks Holdings, Inc. has recorded a -31.10% price change, indicating a weak performance relative to the broader market.

Ginkgo Bioworks Holdings, Inc. (DNA) 7-Day Stock Price Changes

Over the past seven days, Ginkgo Bioworks Holdings, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $8.80 to the latest recorded price of $9.43, reflecting an intraday change of +12.86%. Daily movements highlight shifts in trading volume (13,293), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, DNA has delivered a +402.87% return over the past month and a -31.10% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Ginkgo Bioworks Holdings, Inc. (DNA)

You can buy and trade DNA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for DNA and Execute Your Trade

Open the trading page, enter DNA in the search bar, select the amount of DNA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Ginkgo Bioworks Holdings, Inc. (DNA)?

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Ginkgo Bioworks Holdings, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees	834
Sector	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Company Website	https://www.ginkgobioworks.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Ginkgo Bioworks Holdings, Inc.?

The latest trading price for Ginkgo Bioworks Holdings, Inc. (Common Stock) is $ 9.43, compared with a previous closing price of $ 8.32. That means the stock has moved +12.86% so far today. Intraday price updates and recent trading activity for DNA can be tracked on the live chart and quote section on this page.

2.Is Ginkgo Bioworks Holdings, Inc. stock going up or down?

Looking at recent performances, DNA has returned +402.87% over the past month, -20.73% over the last six months and -31.10% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Ginkgo Bioworks Holdings, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does DNA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Ginkgo Bioworks Holdings, Inc. has traded between a low of $ 5.00 and a high of $ 17.58. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether DNA is currently nearer the top or the bottom of its one-year trading band.

4.How is Ginkgo Bioworks Holdings, Inc. classified by sector and industry?

Ginkgo Bioworks Holdings, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector, within the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry group and the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry. In practice, this means Ginkgo Bioworks Holdings, Inc. is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing DNA's sector and industry classification helps when building diversified portfolios, comparing Ginkgo Bioworks Holdings, Inc. with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector and BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry.

5.Where is Ginkgo Bioworks Holdings, Inc. listed and how large is it by market value?

Ginkgo Bioworks Holdings, Inc. is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 457.33M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Ginkgo Bioworks Holdings, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does DNA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -5.60 summarises how much profit Ginkgo Bioworks Holdings, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Ginkgo Bioworks Holdings, Inc.'s financial performance over time?

To follow Ginkgo Bioworks Holdings, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how DNA is performing and how the market is responding.

8.When is Ginkgo Bioworks Holdings, Inc. expected to report earnings?

Ginkgo Bioworks Holdings, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for DNA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Ginkgo Bioworks Holdings, Inc.'s earnings reports?

Ginkgo Bioworks Holdings, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether DNA is meeting, beating or missing expectations.

10.How can I stay informed about Ginkgo Bioworks Holdings, Inc.'s results and guidance?

You can stay up to date on Ginkgo Bioworks Holdings, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for DNA on this page helps you see how new information is being reflected in the stock.

11.Does Ginkgo Bioworks Holdings, Inc. pay a regular cash dividend to its shareholders?

Ginkgo Bioworks Holdings, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor DNA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for DNA?

Based on the latest earnings data, DNA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Ginkgo Bioworks Holdings, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Ginkgo Bioworks Holdings, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Ginkgo Bioworks Holdings, Inc.?

Ginkgo Bioworks Holdings, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is DNA valued in terms of P/E ratio and EPS?

Ginkgo Bioworks Holdings, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -5.60. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Ginkgo Bioworks Holdings, Inc.'s earnings. Comparing DNA's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Ginkgo Bioworks Holdings, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Dow Inc.

DOW

Ford Motor Company

Franco-Nevada Corporation

FNV

GE Aerospace

The Magnum Ice Cream Company N.V.

MICC

Top Gainers

Browse today's leading gainers in the US stock market

Amprius Technologies, Inc.

AMPX

Bloom Energy Corporation

Cango Inc.

CANG

Ginkgo Bioworks Holdings, Inc.

DNA

Envista Holdings Corporation

NVST

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

DNA-to-USD Calculator

Amount

DNA

USD

1 DNA = 9.425 USD